English: Benzoic acid, 2-ethoxy-4- [2-[[(1S)-3-methyl-1-[2-(1piperidinyl)phenyl]butyl]am ino]-2-oxoethyl]Phosphonic acid, (1,2- epoxypropyl)-, (1R,2S)-(-)Phosphonic acid, mono(3- methyloxiranyl) ester, (2Rcis)Benzenesulfonamide, 4-[5- (4-methylphenyl)-3(trifluoromethyl)-1H- pyrazol-1-yl]Inosine, compd. with 1- (dimethylamino)-2-propanol 4(acetylamino)benzoate (salt) (1:3) 1-165-Hematopoietic cell growth factor KL (human clone V19.8:hSCF162), N-L- methionyl-, dimer L-Leucine, N-formyl-, (1S)- 1-[[(2S,3S)-3-hexyl-4-oxo- 2oxetanyl]methyl]dodecyl ester L-Cysteinamide, N6- (aminoiminomethyl)-N2-(3mercapto-1-oxopropyl)-L- lysylglycyl-L-.alpha.- aspartylL-tryptophyl-L- prolyl-, cyclic (1.fwdarw.6)-disulfide 2-Cyclopentene-1-methanol, 4-[2-amino-6(cyclopropylamino)-9H- purin-9-yl]-, (1S,4R)2-Thiophenepropanoic acid, .alpha.-[[2-butyl-1-[(4carboxyphenyl)methyl]-1H- imidazol-5-yl]methylene]-, (.alpha.E)1H-Indole-3-ethanamine, N,N-dimethyl-5-(1H-1,2,4triazol-1-ylmethyl)Benzenesulfonamide, 4- (aminomethyl)Immunoglobulin G1, anti- (human p185neu receptor) (human-mouse monoclonal rhuMab HER2 .gamma.1chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer [1,1'-Biphenyl]-2- carboxylic acid, 4'-[(1,4'- dimethyl-2'propyl[2,6'-bi- 1H-benzimidazol]-1'- yl)methyl]Icodextrin D-glycero-D-galacto-Non-2- enonic acid, 5(acetylamino)-4- [(aminoiminomethyl)amino]- 2,6anhydro-3,4,5-trideoxyHirudin (Hirudo medicinalis isoform HV1), 1-L-leucine2-L-threonine-63-desulfoImidazo[5,1-d]-1,2,3,5- tetrazine-8-carboxamide, 3,4dihydro-3-methyl-4-oxo2(5H)-Furanone, 4-[4- (methylsulfonyl)phenyl]-3- phenyl2,4-Thiazolidinedione, 5- [[4-[2-(methyl-2pyridinylamino)ethoxy]pheny l]methyl]-
French: L­Leucine, N­formyl­, (1S)­ 1­[[(2S,3S)­3­hexyl­4­oxo­ 2­ oxetanyl]methyl]dodecyl ester L­Cysteinamide, N6­ (aminoiminomethyl)­N2­(3­ mercapto­1­oxopropyl)­L­ lysylglycyl­L­.alpha.­ aspartyl­ L­tryptophyl­L­ prolyl­, cyclic (1.fwdarw.6)­disulfide 2­Cyclopentene­1­methanol, 4­[2­amino­6­ (cyclopropylamino)­9H­ purin­9­yl]­, (1S,4R)­ 2­Thiophenepropanoic acid, .alpha.­[[2­butyl­1­[(4­ carboxyphenyl)methyl]­1H­ imidazol­5­yl]methylene]­, (.alpha.E)­ 1H­Indole­3­ethanamine, N,N­dimethyl­5­(1H­1,2,4­ triazol­1­ylmethyl)­ Benzenesulfonamide, 4­ (aminomethyl)­ Immunoglobulin G1, anti­ (human p185neu receptor) (human­mouse monoclonal rhuMab HER2 .gamma.1­ chain), disulfide with human­mouse monoclonal rhuMab HER2 light chain, dimer [1,1'­Biphenyl]­2­ carboxylic acid, 4'­[(1,4'­ dimethyl­2'­ propyl[2,6'­bi­ 1H­benzimidazol]­1'­ yl)methyl]­ Icodextrin D­glycero­D­galacto­Non­2­ enonic acid, 5­ (acetylamino)­4­ [(aminoiminomethyl)amino]­ 2,6­ anhydro­3,4,5­trideoxy­ Hirudin (Hirudo medicinalis isoform HV1), 1­L­leucine­ 2­L­threonine­63­desulfo­ Imidazo[5,1­d]­1,2,3,5­ tetrazine­8­carboxamide, 3,4­ dihydro­3­methyl­4­oxo­ 2(5H)­Furanone, 4­[4­ (methylsulfonyl)phenyl]­3­ phenyl­ 2,4­Thiazolidinedione, 5­ [[4­[2­(methyl­2­ pyridinylamino)ethoxy]pheny l]methyl]­ D­Glucose, 2­deoxy­6­O­[2­ deoxy­2­[[(3R)­1­oxo­3­[(1­ oxododecyl)oxy]tetradecyl]a mino]­3­O­[(3R)­1­oxo­3­ [(1­ oxotetradecyl)oxy]tetradecy l]­4­O­phosphono­ .beta.­D­ glucopyranosyl]­2­[[(3R)­1­ oxo­3­[(1­ox .alpha.­D­Glucopyranose, 2­ deoxy­6­O­[2­deoxy­2­ [[(3R)­1­oxo­3­[(1­ oxododecyl)oxy]tetradecyl]a mino]­3­ O­[(3R)­1­oxo­3­ [(1­ oxotetradecyl)oxy]tetradecy l]­4­O­ phosphono­.beta.­D­ glucopyranosyl]­2­[[(3R)­ 3H­21,18­Nitrilo­1H,22H­ pyrrolo[2,1­ c][1,8,4,19]dioxadiazacyclo tetracosine­ 1,7,16,22(4H,17H)­tetrone, 26­[[2­ (diethylamino)ethyl]sulfony l]­8,9,14,15,24,25,26,26a­ octahydro­14­hydroxy­4,12­ dimethyl­3­(